500 related articles for article (PubMed ID: 30098475)
1. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.
Stanciu AE; Stanciu MM; Vatasescu RG
Cytokine; 2018 Nov; 111():13-19. PubMed ID: 30098475
[TBL] [Abstract][Full Text] [Related]
2. Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study.
Truong QA; Januzzi JL; Szymonifka J; Thai WE; Wai B; Lavender Z; Sharma U; Sandoval RM; Grunau ZS; Basnet S; Babatunde A; Ajijola OA; Min JK; Singh JP
Heart Rhythm; 2014 Dec; 11(12):2167-75. PubMed ID: 25014756
[TBL] [Abstract][Full Text] [Related]
3. Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects.
Stanciu AE; Vatasescu RG; Stanciu MM; Iorgulescu C; Vasile AI; Dorobantu M
Clin Biochem; 2013 Feb; 46(3):230-4. PubMed ID: 23159290
[TBL] [Abstract][Full Text] [Related]
4. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
[TBL] [Abstract][Full Text] [Related]
5. Effects of ivabradine therapy on heart failure biomarkers.
Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
[TBL] [Abstract][Full Text] [Related]
6. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
[TBL] [Abstract][Full Text] [Related]
7. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
[TBL] [Abstract][Full Text] [Related]
9. The level of NT-proBNP in ambulatory patients with chronic heart failure with preserved ejection fraction of the left ventricle.
Kirillova VV; Sokolova LA; Meshchaninov VN; Pershanova VI
Ter Arkh; 2018 Sep; 90(9):68-72. PubMed ID: 30701738
[TBL] [Abstract][Full Text] [Related]
10. [Biomarkers of inflammation in patients with chronic heart failure and implanted devices for cardiac resynchronization therapy].
Kuznetsov VA; Soldatova AM; Enina TN; Shebeko PV; Rychkov AIu; Mel'nikov NN; Zateĭshchikov DA
Kardiologiia; 2012; 52(8):38-43. PubMed ID: 23098397
[TBL] [Abstract][Full Text] [Related]
11. The association between NT-proBNP levels, functional capacity and stage in patients with heart failure.
Karabulut A; Kaplan A; Aslan C; Iltumur K; Toprak G; Toprak N
Acta Cardiol; 2005 Dec; 60(6):631-8. PubMed ID: 16385925
[TBL] [Abstract][Full Text] [Related]
12. Effect of atorvastatin on plasma NT-proBNP and inflammatory cytokine expression in patients with heart failure.
Duan HY; Liu DM; Qian P; Wang SL; Yan LJ; Wu JT; Yang HT; Fan XW; Chu YJ
Genet Mol Res; 2015 Dec; 14(4):15739-48. PubMed ID: 26634541
[TBL] [Abstract][Full Text] [Related]
13. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.
Tsutamoto T; Sakai H; Nishiyama K; Tanaka T; Fujii M; Yamamoto T; Horie M
Circ J; 2007 Dec; 71(12):1873-8. PubMed ID: 18037739
[TBL] [Abstract][Full Text] [Related]
14. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
[TBL] [Abstract][Full Text] [Related]
16. Correlation between NT-proBNP values and changes in functional capacity in patients with chronic heart failure.
Fernandes R; Feliciano J; Soares RM; Mamede A; Ramos R; Miranda F; Silva S; Timóteo AT; Abreu A; Ferreira R
Rev Port Cardiol; 2007 Dec; 26(12):1329-44. PubMed ID: 18338663
[TBL] [Abstract][Full Text] [Related]
17. [Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
Zhao XY; Yang YJ; Zhang J; Kang LM; Wei BQ; Gao XJ; Lü R; Zhang CL
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):486-90. PubMed ID: 19927626
[TBL] [Abstract][Full Text] [Related]
18. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation.
Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M
Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263
[TBL] [Abstract][Full Text] [Related]
19. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
[TBL] [Abstract][Full Text] [Related]
20. [Changes of serum N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases and its clinical significance].
Yang CL; Qiu YR; Zhou F; Feng PF
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):866-9. PubMed ID: 18504223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
